Life Spine’s IP portfolio comprises over 265 patents and applications with a strong position around expandable interbody technology. The company has been granted over 11 expandable FDA 510(k) clearances, with an additional 17 pending.
Michael Butler, Life Spine President and CEO, said, “Our strong intellectual property position and R&D dedication allows us to serve our customers with the best performing products possible. Our Micro Invasive™ expandable products are gaining consistent adoption as we position ourselves for some of the largest growth in the industry.”
Life Spine’s IP portfolio comprises over 265 patents and applications with a strong position around expandable interbody technology. The company has been granted over 11 expandable FDA 510(k) clearances, with an additional 17 pending.
Life Spine’s IP portfolio comprises over 265 patents and applications with a strong position around expandable interbody technology. The company has been granted over 11 expandable FDA 510(k) clearances, with an additional 17 pending.
Michael Butler, Life Spine President and CEO, said, “Our strong intellectual property position and R&D dedication allows us to serve our customers with the best performing products possible. Our Micro Invasive™ expandable products are gaining consistent adoption as we position ourselves for some of the largest growth in the industry.”
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
